Investors & Media International Stem Cell Corporation Announces Operating Results for the Three-Months Ended March 31, 2016 International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results International Stem Cell Corporation to Raise $6.3 Million Through a Private Placement to Fund Phase I Clinical Trial International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products International Stem Cell Corporation Announces Operating Results for the Three- and Nine-Months Ended September 30, 2015 International Stem Cell Corporation Moves Forward With Parkinson's Disease Clinical Trials in Australia International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015 2 3 4 5 6 7 8 9 10 11 12 << < > >>